ST MARYS HOSPITAL SUPERIOR — History
CCN 521329 | 3-year financial timeline | COVID resilience: 64/100
🛡️ Public data only — no PHI permitted on this instance.
$98M
Latest Revenue (FY2022)
+10.1%
Revenue CAGR (3yr)
18.6%
Financial Timeline
| Metric | FY2020 | FY2021 | FY2022 | YoY (Latest) | CAGR |
|---|---|---|---|---|---|
| Net Patient Revenue | $81M | $90M | $98M | +9.1% | +10.1% |
| Operating Expenses | $66M | $76M | $80M | +5.7% | +9.9% |
| Operating Margin | 18.2% | 15.9% | 18.6% | +16.6% | +1.1% |
| Net Income | $15M | $14M | $18M | +27.2% | +11.3% |
| Licensed Beds | 16 | 16 | 16 | +0.0% | +0.0% |
| Total Patient Days | 3,336 | 3,763 | 3,850 | +2.3% | +7.4% |
| Medicare Day % | 65% | 53% | 56% | +5.7% | -6.6% |
| Medicaid Day % | 6% | 9% | 3% | -65.4% | -26.2% |
COVID Impact & Recovery
Resilience Score: 64/100 — Moderate — some COVID impact but recovering
Revenue recovery from FY2020 to FY2022: +21.3% ($81M → $98M)
FY2020 captured the initial COVID shock. Strong recovery indicates operational resilience and payer diversification.
Trend Summary
Revenue▲ Growing
Operating Margin▲ Growing
Beds▶ Stable
Medicare Mix▲ Growing
vs State Average ()
Revenue Growth
+10.1%
This Hospital
+7.6%
State Avg
Latest Margin
18.6%
This Hospital
-4.6%
State Avg
Projections (FY2023-2025)
Extrapolated from 3-year trend using linear projection. Does not account for regulatory or market changes.
| Year | Revenue (proj) | Margin (proj) |
|---|---|---|
| FY2023 (proj) | $107M | 18.7% |
| FY2024 (proj) | $115M | 18.9% |
| FY2025 (proj) | $124M | 19.1% |